Introduction: Proper selection of patient and stent-graft combinations in endovascular aneurysm repair (EVAR) depends on knowledge and experience with the different types of stents that have to be adapted to the patient's unique abdominal aortoiliac anatomy. The aim of this study was to analyze the consistency and variance in EVAR suitability assessment between clinicians. Methods: Worksheets that contained anatomic data derived from computed tomography scans and angiography were compiled for 202 patients. Five clinicians, all experienced in EVAR surgery, assessed the anatomic data on the worksheets for suitability for three types of stent-grafts. The obtained 3030 assessments represented a quantification of the likelihood of success the clinician expected for effective and durable sealing and fixation of the stent-graft in EVAR. The Delphi method was used to determine consensus in the thinking process among clinicians, and analysis was used to determine the proportion of variances in the assessment result between clinicians. Results: With the Delphi method, Cronbach ␣ values of 0.87, 0.87, and 0.90 were reached for the three types of stent-grafts in the second assessment round. The individual clinician-group correlation in round two was between 0.69 and 0. 86 for clinicians 1, 2, 3, and 4. Between clinician 5 and the others, correlation varied between 0.43 and 0.64. The  values ranged between 0.32 and 0.51 among clinicians 1, 2, and 3 . Between clinician 5 and the others, values between 0.08 and 0.29 were reached. Conclusion: EVAR suitability estimation in a cohort of patients is highly consistent in a group of experienced clinicians. The EVAR suitability estimation at the individual patient level varies substantially between clinicians, however. Aggregating expert opinions in abdominal aortic aneurysm anatomic suitability assessment for EVAR had the opportunity to replace individual clinician decision diversification in a more solid and consistent group decision process. ( J Vasc Surg 2006;43:671-6.)
Endovascular aneurysm repair (EVAR) requires preoperative measurement to precisely define the aneurysm morphology and subsequently select the appropriate type of stent-graft. EVAR suitability or "likelihood of success" is a result of the combination of aneurysm morphology and thorough knowledge and experience with different types of stent-grafts. Preoperative EVAR suitability assessment is an important factor in determining successful aneurysm exclusion, minimizing intraoperative difficulties, and endeavoring the likelihood of attaining EVAR durability. [1] [2] [3] [4] [5] [6] [7] [8] [9] Extracting EVAR decision algorithms to quantify the likelihood of success from a large panel of experienced clinicians has the potential to become an EVAR suitability reference guide, thereby protecting patients against an individual clinician's uncertainty. A condition for developing applicable EVAR suitability algorithms is a high consistency in decision-making strategy between individual clinicians for each type of stent-graft.
The aim of the present study was to determine consistency and variance in the preoperative assessment of EVAR suitability between experienced clinicians.
METHODS
Anatomic data from 202 abdominal aortoiliac aneurysm (AAA) patients from two high-volume teaching hospitals were included in this study. All 202 patients were presented for EVAR assessment in the period 1999 to 2001 (Table I) . For all patients, data from plain and contrastenhanced computed tomography (CT), or calibrated intraarterial digital subtraction angiography (iaDSA), or both, were always available.
In both clinics, a minimum of at least three clinicians performed the standardized measurement procedure of all 202 AAAs. In three cases of neck configuration discrepancy, two more clinicians were involved in the measurement procedure until consensus was reached. 10 A standardized worksheet was used to divide each AAA into 10 segments: suprarenal aorta, infrarenal aortic neck, aneurysm, aortic bifurcation, right and left common iliac artery, right and left external iliac artery, and right and left common femoral artery (Fig 1) . Six characteristics were recorded for each segment: diameter, length, percentage of thrombus, percentage of calcification, angulation, and shape (Table II) .
When both were available, we preferred images of CT scans for diameter measurement and iaDSA for length measurement. Diameter was measured from intima to intima. The percentage of thrombus and percentage of calcification were defined as the percentage of the circumference of the total segment assessed from plain CT scans and contrast-enhanced CT-scans, respectively; angulation was defined as the sharpest central lumen line angulation in one or between two segments.
A total of 72 different criteria were used to describe the full anatomic characteristics of each individual AAA. The outcomes of all these measurements were tabulated on an AAA stent-grafting assessment worksheet (Table II) . According to the aim of this study, we removed other patient characteristics such as age and comorbidity from the worksheet, providing the experts with only the numeric anatomic AAA data to assess the anatomic suitability for EVAR.
Suitability assessment. One interventional radiologist and two vascular surgeons from one hospital and one vascular surgeon and one radiologist from two other hos-pitals were part of this study. Each clinician had an individual EVAR experience of at least 100 procedures. The five clinician independently assessed EVAR suitability by using the numeric anatomic data of these 202 AAA worksheets.
All of the commercially available configurations of three stent-grafts-the Talent standard, the Talent custom-made, and the AneuRx (Medtronic AVE, Santa Rosa, Calif)-were available for selection.
EVAR suitability was defined as the clinician's expectation for the likelihood of an effective and durable sealing and fixation preventing proximal or distal leakage (type I endoleak) or stent-graft disconnection (type III endoleak). Because each AAA consisted of 10 segments, the overall suitability score for EVAR consisted of the aggregation of the score of these 10 segments by the individual clinician. We did not analyze the segmental information in this study.
The suitability for EVAR expressed by each clinician had to be rated on a 0 to 100 scale, between very suitable (0 to 49) and not suitable (100). To categorize the suitability, five clinically relevant asymmetrical groups (Fig 2) were defined for this study in dialogue with three other EVAR specialists not related to the assessments. The more difficult cases were rated in three of the five categories, ranging from 50 to 99, rendering the clinical relevancy. For intermediate or highly suitable cases, no subcategorization was made, thereby reducing the total number of categories needed in five. Based on the criteria and the available stent-grafts, the clinicians used the data from 202 patients to make a total of 3030 EVAR suitability assessments in the first round.
Statistical analyses. The Delphi method 11, 12 was used to measure the consensus in EVAR suitability estimation for the 202 different AAA cases. Each worksheet was seen as an item of an "assessment questionnaire." The five clinicians evaluated each item with a suitability score for EVAR for each of the three stent-grafts separately. Applying the Delphi method, we created five clinician-ranking scores expressing the likelihood of success on a scale from 0 to 100 for each item for each type of stent-graft ( Fig 3) . We used Cronbach's ␣ as a coefficient for internal consistency between the five clinicianranking scores. The more the five clinicians were equal in their way of ranking EVAR suitability for the 202 worksheet cases, the closer the Cronbach ␣ value was to 1.0. A Cronbach ␣ value of 0.7 to 0.8 is regarded as satisfactory consistency between clinicians. For clinical application, values near 0.90 are recommended. 11, 12 To determine individual clinician-group correlation, we used the inter-item correlation matrix. 11 Two Delphi assessment rounds were conducted for each clinician. In the first round, all 202 assessments had to be made. In the second round, the clinicians had to reassess their outliers, which were defined as EVAR suitability assessments that deviated more than one EVAR suitability category (Fig 2) of the clinician's mean EVAR suitability score. In this second round, clinicians were blinded for the outcome of their assessments in the first assessment round. They knew, however, that the assessment they made was different from the group assessment and reassessment was asked. If an individual assessment after the second round persistently deviated more than twice the standard error of the mean, the chief author discussed the case with the clinician, using the segmental scoring information as a check for misinterpretation of numeric anatomic data. If a misinterpretation was excluded, the suitability assessment of a case was considered as a consistent outlier. After the second round, the Delphi process was terminated because clinically applicable Cronbach ␣ values were reached.
With the method, clinical relevant variances in the outcome of suitability assessment between clinicians for individual patient and stent-graft combinations were determined. The following nomenclature of Landis and Koch, 13 was used: poor (, Ͻ0), slight (, 0 to 0.20), fair (, 0.21 to 0.40), moderate (, 0.41 to 0.60), substantial (, 0.61 to 0.80), and almost perfect (, 0.80 to 1.00) agreement. Four categories of overall EVAR suitability assessments were defined to calculate values: group 1, Ͻ50; group 2, 50 to 94; group 3, 95 to 99; group 4, 100. This redefinition was necessary because our original categorization in five groups (Fig 2) did not have any assessment scores in the 99 groups for some clinicians, so could not be calculated.
The statistical analyses were performed with SPSS version 12.0 (SPSS Inc., Chicago, Ill) for Windows (Microsoft, Redmond, Wash).
RESULTS
In round one for the Talent standard, Talent custommade, and AneuRx stent-graft assessments, Cronbach ␣ values of 0.79, 0.81, and 0.85, respectively, were found. The second round increased the Cronbach ␣ values to 0.87, 0.87, and 0.90, respectively. The individual clinician group correlation over two Delphi iterations is presented in Table III . In all three stent-graft assessments, the individual clinician-group correlation in round two was between 0.69 and 0.86 for clinicians 1, 2, 3, and 4. Compared with clinician 5, a persisting clinician-group correlation of Ͻ0.64 was seen.
The values (Table IV) ranged between 0.32 and 0.51 among clinicians 1, 2, and 3. Between clinician 5 and the others, values between 0.08 and 0.29 were reached.
For eight of 30 clinician-clinician comparisons, the value was moderate, for only one of 30 was the value substantial at 0.62, which indicates an agreement tendency.
DISCUSSION
This study clearly demonstrated that aggregating expert opinions in AAA anatomic suitability assessment for EVAR had the opportunity to replace individual clinician decision diversification with a more solid and consistent group decision process. 
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Left ext iliac CT, computed tomography; MRA, magnetic resonance angiography; DSA, digital subtraction angiography. The decision-making strategy for EVAR suitability estimation in a group of AAAs was satisfyingly consistent between experienced clinicians. The high Cronbach ␣ values indicated a clinically applicable equivalent thinking process or group consensus. Only for clinician 5 was the clinician-group correlation low. This indicated that the decision-making strategy of clinician 5 was a consistent outlier compared with the other four clinicians. Clinician 5 had a tendency to rank EVAR suitability in extreme categories. The other four clinicians had a more deliberate assessment of the AAA data for EVAR.
The analysis demonstrated that the estimation on the level of each individual patient frequently varies one, or even more, categories between clinicians. Clearly, estimating the level of EVAR suitability for an individual AAA anatomy dataset is mostly an expression of objective clinical knowledge, intuition, and the clinician's past experience. From a patient perspective, this indicates that estimating the chance of effective and durable sealing and fixation of the stent-graft depends not only on the unique morphology of the patient but, importantly for a significant part, also on the risk assessment of each individual clinician.
The clinicians were selected because of their educational expertise as proctors and they were familiar with assessing numeric anatomic AAA data for EVAR as used in this study. Also, the clinicians had different backgrounds in their original vascular traineeship. These facts contributed to minimize biasing of the Delphi method. As mentioned before, the clinicians were only aware of the numeric anatomic AAA data, although of course in practice, the definitive decision for or against EVAR application is only possible by balancing not only the anatomic characteristics but also the many other relevant patient characteristics. According to the aim of this study, acquaintance with other patient data or reviewing the original CT or iaDSA images was not allowed, thereby excluding, among other things, the influence of the interobserver variation of AAA measurement. 10 Even high-volume AAA-EVAR teams will not develop enough experience to offer the individual patient comprehensive and balanced advice on EVAR suitability for all of the different commercially available stent-grafts. Moreover, EVAR is a rapidly evolving technology. The frequent introduction of new types of stent-grafts with their own unique characteristics results in more intuitive rather than knowledgebased decision-making in daily practice. 14, 15 
CONCLUSION
Extracting EVAR suitability decision algorithms from a large panel of experienced clinicians has the potential to become a gold standard if the algorithms are validated, easily accessible, and continuously updated with the latest peerreviewed knowledge on the outcome of EVAR. The validation process of these algorithms should include future studies comparing the ultimate clinical outcome of individual patients with the initial suitability assessment, supporting the hypothesis that differences in preoperative suitability assessment predicted the ultimate results. Developing such a gold standard protects patients against individual clinician misinterpretation and against delay in the introduction of new EVAR knowledge in the medical community. 14, 15 We are grateful to A. Stam (research assistant Medisch Spectrum Twente) and P. Oude Groothuis (field sales supervisor Medtronic AVE, Kerkrade, The Netherlands) for their help with conducting and performing this study. 
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